August 13, 2018

What's next for Mayo Clinic as it welcomes its next CEO

Daily Briefing

    The Mayo Clinic Board of Trustees on Friday announced Gianrico Farrugia, the vice president of Mayo Clinic and CEO of Mayo Clinic in Florida, will succeed John Noseworthy as president and CEO of the Mayo Clinic when he retires at the end of the 2018.

    Background

    Noseworthy in February announced that he would step down as Mayo Clinic's president and CEO after serving in the role for nine years. Noseworthy at the time said he decided to step down because "Mayo has a tradition of rotating leaders every four to eight years in all the medical departments, and the CEO is renewed annually and generally serves for seven to 10 years." 

    Noseworthy noted that he would be ending his tenure at a time in which Mayo Clinic is "in a very strong position in … quality, safety, education, research activities, and … financial performance."

    About Farrugia

    According to the Clinic, Farrugia has served as vice president of Mayo Clinic and CEO of Mayo Clinic in Florida since January 2015.

    In his current role, Farrugia, who also is a faculty member in biomedical engineering at Mayo Clinic Graduate School of Biomedical Sciences, has led more than 6,400 staff members and overseen significant investments in the Clinic's Florida campus. For instance, Farrugia oversaw the opening of the Harry T. Mangurian Jr. Building—a 190,000-square-foot building for patients receiving cancer, neurology, and neurosurgical care.

    Mayo said its Florida campus became the destination medical center of the Southeast during Farrugia's tenure, and U.S. News & World Report in 2017 named the Mayo Clinic the best hospital in Florida.

    Prior to his work at Mayo's Florida campus, Farrugia served as the director of Mayo Clinic's Center for Individualized Medicine, which incorporates genomics into routine clinical care. Farrugia also co-founded the Center for Innovation at Mayo Clinic.

    Overall, Farrugia has served as a Mayo Clinic physician for 30 years. He has been appointed to Mayo Clinic's Division of Gastroenterology and Hepatology, Department of Internal Medicine, and the Department of Physiology and Biomedical Engineering.

    Comments

    Farrugia said, "I am humbled and proud to follow and build upon this success with the best staff in the world. While sea change continues to sweep through health care, I look forward to harnessing innovation, a hallmark of Mayo Clinic, to transform health care for the benefit of patients everywhere."

    Noseworthy said, "Farrugia is a visionary and servant leader who brings with him a wealth of experience and knowledge—both as an innovator and an executive. In partnership with our staff across Mayo Clinic, and with a deep commitment to our values and mission, he will affirm Mayo Clinic's position as the global health care leader for generations to come."

    Samuel Di Piazza, who chairs Mayo Clinic's Board of Trustees, said, "Farrugia brings an impressive depth of experience to this role. A prolific investigator and inventor, and an accomplished executive, he has been at the leading edge of innovation across the breadth of Mayo's clinical and research mission" (Karnowski, AP/Washington Post, 8/10; Mayo Clinic release, 8/10; Snowbeck, Minneapolis Star Tribune, 8/10; Richert, MPR News, 8/10).

    12 things your C-suite needs to know in 2018

    Uncertainty abounds—and health systems need to face it head on. Download our new briefing to learn 12 key insights for senior executives working to drive hospital and health system success in 2018.

    Download the Briefing

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.